US 11422132
Peptides and uses thereof for diagnosing and treating myasthenia gravis
granted A61KA61K38/00A61K47/6849
Quick answer
US patent 11422132 (Peptides and uses thereof for diagnosing and treating myasthenia gravis) held by The Regents of the University of California expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K38/00, A61K47/6849, A61P, A61P21/04